Vitrolife AB (publ) (STO:VITR)
Sweden flag Sweden · Delayed Price · Currency is SEK
156.80
+1.10 (0.71%)
May 6, 2025, 4:53 PM CET

Vitrolife AB Revenue

Vitrolife AB had revenue of 842.00M SEK in the quarter ending March 31, 2025, with 0.12% growth. This brings the company's revenue in the last twelve months to 3.61B, up 3.17% year-over-year. In the year 2024, Vitrolife AB had annual revenue of 3.61B with 2.76% growth.

Revenue (ttm)
3.61B
Revenue Growth
+3.17%
P/S Ratio
5.84
Revenue / Employee
3.14M
Employees
1,169
Market Cap
21.09B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20243.61B97.00M2.76%
Dec 31, 20233.51B278.00M8.60%
Dec 31, 20223.23B1.55B92.39%
Dec 31, 20211.68B435.43M34.96%
Dec 31, 20201.25B-234.56M-15.85%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Swedish Orphan Biovitrum AB 26.24B
Sectra AB 3.30B
Getinge AB 35.57B
Camurus AB 1.87B
Medicover AB 23.56B
AddLife AB 10.42B
Bonesupport Holding AB 997.85M
Vimian Group AB 4.24B
Revenue Rankings

Vitrolife AB News

More News